Literature DB >> 12671027

A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins.

Stephen T Thuahnai1, Sissel Lund-Katz, G M Anantharamaiah, David L Williams, Michael C Phillips.   

Abstract

Competitive binding experiments were performed using Y1-BS1 adrenal cells to provide information about the interaction of HDL apolipoproteins with scavenger receptor class B, type I (SR-BI). Exchangeable apolipoproteins apolipoprotein A-I (apoA-I), apoA-II, apoE-2, apoE-3, and apoE-4 as phospholipid complexes bind like HDL3 to SR-BI via their multiple amphipathic alpha-helices; the concentrations required to reduce the binding of HDL3 to SR-BI by 50% (IC50) were similar and in the range of 35-50 microgram protein/ml. In the case of apoA-I, peptides corresponding to segments 1-85, 44-65, 44-87, 149-243, and 209-241 all had the same IC50 as each other (P = 0.86), showing that a specific amino acid sequence in apoA-I is not responsible for the interaction with SR-BI. The distribution of charged residues in the amphipathic alpha-helix affects the interaction, with class A and Y helices binding better than class G* helices. Synthetic alpha-helical peptides composed of either l or d amino acids can bind equally to the receptor. Association with phospholipid increases the amount of apolipoprotein binding to SR-BI without altering the affinity of binding. Lipid-free apolipoproteins compete only partially with the binding of HDL to SR-BI, whereas lipidated apolipoproteins compete fully. These results are consistent with the existence of more than one type of apolipoprotein binding site on SR-BI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671027     DOI: 10.1194/jlr.M200429-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

Review 1.  Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.

Authors:  Wen-Jun Shen; Jie Hu; Zhigang Hu; Fredric B Kraemer; Salman Azhar
Journal:  Metabolism       Date:  2014-03-21       Impact factor: 8.694

Review 2.  Genetic alterations affecting cholesterol metabolism and human fertility.

Authors:  Anthony M DeAngelis; Meaghan Roy-O'Reilly; Annabelle Rodriguez
Journal:  Biol Reprod       Date:  2014-08-13       Impact factor: 4.285

Review 3.  The molecular aspects of absorption and metabolism of carotenoids and retinoids in vertebrates.

Authors:  Made Airanthi K Widjaja-Adhi; Marcin Golczak
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-11-23       Impact factor: 4.698

Review 4.  SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux.

Authors:  Wen-Jun Shen; Salman Azhar; Fredric B Kraemer
Journal:  Annu Rev Physiol       Date:  2017-11-10       Impact factor: 19.318

Review 5.  High density lipoprotein structure-function and role in reverse cholesterol transport.

Authors:  Sissel Lund-Katz; Michael C Phillips
Journal:  Subcell Biochem       Date:  2010

6.  Morbid obesity-related changes in the expression of lipid receptors, transporters, and HSL in human sperm.

Authors:  Berniza Calderón; Lydia Huerta; María Emilia Casado; José Manuel González-Casbas; José Ignacio Botella-Carretero; Antonia Martín-Hidalgo
Journal:  J Assist Reprod Genet       Date:  2019-01-18       Impact factor: 3.412

7.  Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI.

Authors:  Thomas J F Nieland; Shangzhe Xu; Marsha Penman; Monty Krieger
Journal:  Biochemistry       Date:  2011-02-25       Impact factor: 3.162

Review 8.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

9.  Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.

Authors:  Ian R Corbin; Kenneth K Ng; Lili Ding; Andrea Jurisicova; Gang Zheng
Journal:  Nanomedicine (Lond)       Date:  2012-10-15       Impact factor: 5.307

10.  High-Density Lipoproteins for Therapeutic Delivery Systems.

Authors:  R Kannan Mutharasan; Linda Foit; C Shad Thaxton
Journal:  J Mater Chem B       Date:  2015-11-24       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.